Research articlePublished 21 Mar 2022

Brain Targeting of Duloxetine Nanoemulsion: In vivo Pharmacokinetic and Bio-distribution Studies

Authors: Gurpreet Singh, Navleen Kaur Sidhu, Garima Khanna, Amita Sarwal, Anurag Kuhad

Journal of Developing Drugs

Volume 11 · Issue 2 · Pages 1–10

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Duloxetine is a potent dual reuptake inhibitor of serotonin and norepinephrine receptors. Due to extensive first- pass metabolism, it has a major limitation of low and variable oral bioavailability. The present study aimed to develop a kinetically stable nanoemulsion using oil, surfactant, and co-surfactant for the better management of the major depressive disorder. The nanoemulsion was prepared by an aqueous titration method. The developed formulation was evaluated for pH, globule size, Transmission Electron Microscopy (TEM), iscosity, transmittance and further it was investigated for in vivo pharmacokinetic and bio-distribution study. According to the results of in vivo pharmacokinetic study in wistar rats, intranasal administration of duloxetine nanoemulsion in the brain had shorter Tmax compared with that of intravenous administration. The brain/blood ratios of duloxetine intranasal nanoemulsion, duloxetine intranasal solution, and duloxetine intravenous solution were 4.42 ± 0.09, 2.18 ± 0.14 and 0.19 ± 0.002 respectively. The higher drug targeting efficiency (381%) and direct transport percentage (73.7%) of duloxetine intranasal nanoemulsion as compared to other formulations indicate its better efficacy in the brain. In order to investigate the localization of duloxetine emulsion in brain confocal laser scanning microscopy was carried out using Rhodamine-123 (ROD-123) as a marker.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

More from this journal

The newest in Journal of Developing Drugs.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Gurpreet Singh”
  • BylineArticles whose byline prints “Navleen Kaur Sidhu”
  • BylineArticles whose byline prints “Garima Khanna”
  • BylineArticles whose byline prints “Amita Sarwal”
  • BylineArticles whose byline prints “Anurag Kuhad”